Clinical Trial Update: Bioavailability Study of Clonazepam ODT Under Fasting Conditions [Phase 1]

View source ↗

Summary

This document notes the completion of a Phase 1 bioavailability study of clonazepam orally disintegrating tablets under fasting conditions to determine bioequiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Panic Disorder

Drugs mentioned

• KLONOPIN (clonazepam)

Snippet

Sponsor: Par Pharmaceutical, Inc. | Conditions: To Determine Bioequivalence Under Fasting Conditions | Phase 1 | Status: COMPLETED